书目名称 | Ganoderma and Health | 副标题 | Pharmacology and Cli | 编辑 | Zhibin Lin,Baoxue Yang | 视频video | | 概述 | Presenting a state-of-the-art report on recent advances concerning Ganoderma.Focusing on advances made over the past 20 years in the pharmacology and clinical applications of Ganoderma.Offering new in | 丛书名称 | Advances in Experimental Medicine and Biology | 图书封面 |  | 描述 | .This book presents a state-of-the-art report on recent advances concerning Ganoderma and where the field is going. Although some older work is also cited, the main focus is on advances made over the past 20 years in the pharmacology and clinical applications of Ganoderma..Ganoderma lucidum (Lingzhi) has been used as a traditional medicine in Asian countries to maintain health and to treat diseases for more than two thousand years. Recently, its value has been demonstrated in preventing and treating certain diseases, such as tumors, liver disorders, renal injury, hypercholesterolemia, obesity, cerebral ischemia reperfusion, bronchitis etc. In addition, laboratory and clinical studies have confirmed that the chemical components of Ganoderma, such as Ganoderma lucidum polysaccharide peptides and triterpenes isolated from the fruiting body of Ganoderma lucidum, produce diverse pharmacological effects. Ganoderma and its components play an important part in antioxidant stress, radical-scavenging, immunomodulation, and intracellular signaling regulation, and accordingly warrant further study. This book systematically reviews the latest advances in our understanding of pharmacology and cl | 出版日期 | Book 2019 | 关键词 | Ganoderma; Lingzhi; Chinese medicine; Pharmacological research; Clinical application | 版次 | 1 | doi | https://doi.org/10.1007/978-981-32-9421-9 | isbn_softcover | 978-981-32-9423-3 | isbn_ebook | 978-981-32-9421-9Series ISSN 0065-2598 Series E-ISSN 2214-8019 | issn_series | 0065-2598 | copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor |
The information of publication is updating
|
|